Division of Clinical Laboratory and Infection Control, Yamagata University Hospital, Yamagata, Japan.
School of Nursing and Midwifery, Monash University, Frankston, VC, Australia.
Antimicrob Resist Infect Control. 2021 Apr 1;10(1):65. doi: 10.1186/s13756-021-00916-9.
Surgical site infections (SSIs) are a significant source of morbidity and mortality in the Asia-Pacific region (APAC), adversely impacting patient quality of life, fiscal productivity and placing a major economic burden on the country's healthcare system. This commentary reports the findings of a two-day meeting that was held in Singapore on July 30-31, 2019, where a series of consensus recommendations were developed by an expert panel composed of infection control, surgical and quality experts from APAC nations in an effort to develop an evidence-based pathway to improving surgical patient outcomes in APAC.
The expert panel conducted a literature review targeting four sentinel areas within the APAC region: national and societal guidelines, implementation strategies, postoperative surveillance and clinical outcomes. The panel formulated a series of key questions regarding APAC-specific challenges and opportunities for SSI prevention.
The expert panel identified several challenges for mitigating SSIs in APAC; (a) constraints on human resources, (b) lack of adequate policies and procedures, (c) lack of a strong safety culture, (d) limitation in funding resources, (e) environmental and geographic challenges, (f) cultural diversity, (g) poor patient awareness and (h) limitation in self-responsibility. Corrective strategies for guideline implementation in APAC were proposed that included: (a) institutional ownership of infection prevention strategies, (b) perform baseline assessments, (c) review evidence-based practices within the local context, (d) develop a plan for guideline implementation, (e) assess outcome and stakeholder feedback, and (f) ensure long-term sustainability.
Reducing the risk of SSIs in APAC region will require: (a) ongoing consultation and collaboration among stakeholders with a high level of clinical staff engagement and (b) a strong institutional and national commitment to alleviate the burden of SSIs by embracing a safety culture and accountability.
手术部位感染(SSI)是亚太地区(APAC)发病率和死亡率的重要来源,对患者的生活质量、财政生产力产生不利影响,并给国家的医疗保健系统带来重大经济负担。本评论报告了 2019 年 7 月 30 日至 31 日在新加坡举行的为期两天的会议的结果,一个由亚太国家的感染控制、外科和质量专家组成的专家小组提出了一系列共识建议,旨在制定一条循证途径,以改善亚太地区的外科患者结局。
专家小组对亚太地区的四个重点领域进行了文献回顾:国家和社会指南、实施策略、术后监测和临床结局。小组就亚太地区 SSI 预防的具体挑战和机遇提出了一系列关键问题。
专家小组确定了在亚太地区减轻 SSI 的几个挑战:(a)人力资源的限制,(b)缺乏适当的政策和程序,(c)缺乏强大的安全文化,(d)资金资源有限,(e)环境和地理挑战,(f)文化多样性,(g)患者意识差,(h)自我责任感有限。为在亚太地区实施指南提出了纠正策略,包括:(a)感染预防策略的机构所有权,(b)进行基线评估,(c)在当地背景下审查基于证据的实践,(d)制定指南实施计划,(e)评估结果和利益相关者反馈,(f)确保长期可持续性。
降低亚太地区 SSI 的风险将需要:(a)利益相关者之间进行持续的协商与合作,并使临床工作人员高度参与,(b)机构和国家对减轻 SSI 负担作出坚定承诺,建立安全文化并承担责任。